Severe Lymphopenia Associated With Shorter PFS in Unresectable, Stage III NSCLC
A single-center, retrospective cohort study was conducted to assess response to treatment and progression of disease in patients with severe lymphopenia undergoing treatment with immune checkpoint inhibitors for NSCLC.